cancer immunology
| 4 min read
Results from Johns Hopkins show a synthetic peptide vaccine was safe and activated mutant-KRAS-specific T cells in 90 percent of participants, offering an early signal that cancer interception may be possible before disease develops.
Available on Demand
Gain insight into how microbiome research is advancing the understanding of cancer biology and therapeutic outcomes.
| 3 min read
Trained on more than 30,000 tumor genomes, MutationProjector offers drug developers a broader framework for connecting cancer genetics to therapy outcomes.
| 4 min read
A new CAR T therapy targets the immune cells that protect tumors, reshaping the tumor microenvironment and enabling host immune clearance.
| 3 min read
New research suggests an unexpected role for T cells during a tumor’s evolution from benign to malignant.
| 4 min read
Mesenchymal stem cells form nanotubes with and donate mitochondria to T cells, boosting the immune cells’ cancer fighting abilities.
| 2 min read
Researchers showed that pancreatic cancer stem cells produce a protein usually made by neutrophils to evade the immune system and keep growing.
| 3 min read
Cowpea mosaic virus stimulated the immune system to treat and prevent metastatic cancers in mice.
| 3 min read
Natural killer cells can sometimes attack beneficial CAR T cell immunotherapies. Now, researchers have discovered why and a potential way to stop them.
| 4 min read
Researchers developed a novel approach for activating neutrophils and boosting anti-tumor immunity.
Page 1 of 1 - 10 Total Items
